Global Cell Harvesting Industry

Global Cell Harvesting Industry

  • October 2022 •
  • 306 pages •
  • Report ID: 5798117 •
  • Format: PDF
Abstract:

What’s New for 2022??

Global competitiveness and key competitor percentage market shares

Market presence across multiple geographies - Strong/Active/Niche/Trivial

Online interactive peer-to-peer collaborative bespoke updates

Access to our digital archives and MarketGlass Research Platform

Complimentary updates for one yearGlobal Cell Harvesting Market to Reach $381.4 Million by 2027
- In the changed post COVID-19 business landscape, the global market for Cell Harvesting estimated at US$233.2 Million in the year 2020, is projected to reach a revised size of US$381.4 Million by 2027, growing at aCAGR of 7.3% over the period 2020-2027. Manual, one of the segments analyzed in the report, is projected to record 7.9% CAGR and reach US$284.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Automated segment is readjusted to a revised 5.6% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $72 Million, While China is Forecast to Grow at 10.4% CAGR
- The Cell Harvesting market in the U.S. is estimated at US$72 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$34.9 Million by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.1% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Select Competitors (Total 30 Featured)
ADS Biotec Inc.
Argos Technologies Inc.
Arthrex, Inc.
Avita Medical
Bertin Bioreagent
BRAND GMBH + CO KG
Biomedical Research & Development Laboratories Inc. (Brandel)
(USA)
Connectorate AG
Cox Scientific Ltd
PerkinElmer Inc.
SP Industries
Terumo BCT Inc.
TOMTEC Imaging Systems GmbH